Purpose
|
Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug. Lornoxicam is approved for use in Japan.
|
Characteristics
|
Tradename: XEFO Source of Compound: synthetic, RO-13-9297 Target: COX inhibitor Receptor: Prostaglandin G/H synthase Status: USAN, INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99?%
|
Formula
|
C13H10ClN3O4S2
|
Solubility
|
DMSO 2 mg/mL,Water <1 mg="" ml="" <="" td="">
1> |